Delays in digitising labs reported by Lupin, Sun Pharma - Digital Intent


Monday, 30 October 2017

Delays in digitising labs reported by Lupin, Sun Pharma

Heads of Lupin, Sun Pharma report delay in digitising labs to prevent quality lapses in factories, as the industry looks to adapt to increased scrutiny from regulators

This is a much more digital world than where pharma companies are and definitely where generic companies are,” Nilesh Gupta, managing director of Lupin Ltd. “I think we should use technology and data a lot more.”
Meanwhile, a project by Sun Pharmaceutical Industries Ltd., India’s largest drug maker, to make all its labs paperless and record all the processes electronically is 12-15 months behind schedule, managing director Dilip Shanghvi said at the same conference. “We underestimated the scale and complexity of what we were trying to do,” he said.
 “We have the technology and capability to develop IT tools in this country,” he said.

No comments:

Post a Comment